logo
Share SHARE
FONT-SIZE Plus   Neg

Bayer Expects HealthCare Sales Of About EUR 20 Bln In 2014 - Quick Facts

German conglomerate Bayer AG (BAYRY.PK,BAYZF.PK) on Wednesday said it sees good perspectives for its businesses in the medium term.

At the "Meet Management" investor conference on Wednesday in Leverkusen, CEO Marijn Dekkers said, "In the life science areas - HealthCare and CropScience - we anticipate further increases in sales and margins through 2014."

The company expects sales of Bayer HealthCare to reach approximately 20 billion euros in 2014, while Bayer CropScience aims to raise sales to more than 8 billion euros.

Bayer added that its MaterialScience segment intends to further strengthen its leading position in the market and plans to achieve volume gains in excess of the rate of global GDP growth.

Dekkers added that the main reason for the optimistic outlook for HealthCare subgroup is its well-stocked development pipeline in Pharmaceuticals. "We believe four of our medicines in late-stage development have blockbuster potential. That means each of these products could achieve peak annual sales of EUR 1 billion or more," he added.

The company added that it aims to successfully commercialize the late-stage pharmaceutical pipeline and take advantage of business opportunities in the emerging markets.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Hormel Foods has agreed to buy organic meat products maker Applegate Farms LLC for about $775 million, as consumers increasingly use natural and organic foods in their diet. Set-top box maker TiVo Inc. (TIVO), Tuesday reported a slight drop in profit for the first quarter despite an increase in revenue, as its bottom line was impacted by a one-time interest expense. Nevertheless, both earnings and revenues for the quarter trumped Wall Street estimates, on subscription growth,... Cloud-based human resource software maker Workday, Inc. said Tuesday after the markets closed that its first quarter net loss widened from last year, as higher costs and expenses more than offset a 57% increase in revenue. However, the company's adjusted loss per share was smaller than what analysts estimated and its quarterly revenue topped analysts' forecast.
comments powered by Disqus
Follow RTT